Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study | Zendy

Wen-Chien Cheng | Zendy; Bing-Ru Wu | Zendy; WeiChih Liao | Zendy; Chih-Yu Chen | Zendy; WeiChun Chen | Zendy; TeChun Hsia | Zendy; ChihYen Tu | Zendy; ChiaHung Chen | Zendy; Wu-Huei Hsu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study

Author(s) -

Wen-Chien Cheng,

Bing-Ru Wu,

WeiChih Liao,

Chih-Yu Chen,

WeiChun Chen,

TeChun Hsia,

ChihYen Tu,

ChiaHung Chen,

Wu-Huei Hsu

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.05.139

Subject(s) - medicine , tiotropium bromide , asthma , copd , exacerbation , logistic regression , lama , eosinophil , univariate analysis , multivariate analysis , lung function , lung

Long-acting muscarinic antagonist (LAMA) tiotropium improved lung function and reduced risks of exacerbation when added on to inhaled corticosteroids (ICS) with or without long-acting B 2 agonists (LABAs) in patients with uncontrolled asthma. However, studies predicting the effectiveness of tiotropium based on patients' clinical characteristics were limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research